Andrew J. Worth

机构：Agios Pharmaceuticals (United States), Massey University · ORCID：0000-0003-3800-4886

发表论文 188 篇 · 总被引 7089 次 · h-index 39

代表论文

• The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations (2018 · Scientific Reports · 被引 211)
• Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity (2018 · Cell Metabolism · 被引 140)
• Discovering Targets of Non-enzymatic Acylation by Thioester Reactivity Profiling (2017 · Cell chemical biology · 被引 102)
• Canine Degenerative Lumbosacral Stenosis: Prevalence, Impact And Management Strategies (2019 · Veterinary Medicine Research and Reports · 被引 54)
• Computer-Assisted Surgery Using 3D Printed Saw Guides for Acute Correction of Antebrachial Angular Limb Deformities in Dogs (2019 · Veterinary and Comparative Orthopaedics and Traumatology · 被引 41)
• Clinical outcomes of patient-specific porous titanium endoprostheses in dogs with tumors of the mandible, radius, or tibia: 12 cases (2013–2016) (2017 · Journal of the American Veterinary Medical Association · 被引 38)